Talk:Gallium (68Ga) gozetotide

	This article was reviewed by member(s) of WikiProject Articles for creation. The project works to allow users to contribute quality articles and media files to the encyclopedia and track their progress as they are developed. To participate, please visit the project page for more information.Articles for creationWikipedia:WikiProject Articles for creationTemplate:WikiProject Articles for creationAfC articles
	This article was accepted from this draft on 5 March 2022 by reviewer Robertsky (talk · contribs).

Health and fitness Low‑importance

	This article is within the scope of WikiProject Health and fitness, a collaborative effort to improve the coverage of health and physical fitness related articles on Wikipedia. If you would like to participate, please visit the project page, where you can join the discussion and see a list of open tasks.Health and fitnessWikipedia:WikiProject Health and fitnessTemplate:WikiProject Health and fitnessHealth and fitness articles
Low	This article has been rated as Low-importance on the project's importance scale.

Medicine: Radiology Mid‑importance

	Medicine portal This article is within the scope of WikiProject Medicine, which recommends that medicine-related articles follow the Manual of Style for medicine-related articles and that biomedical information in any article use high-quality medical sources. Please visit the project page for details or ask questions at Wikipedia talk:WikiProject Medicine.MedicineWikipedia:WikiProject MedicineTemplate:WikiProject Medicinemedicine articles
Mid	This article has been rated as Mid-importance on the project's importance scale.
	This article is supported by the Radiology task force (assessed as Low-importance).

Pharmacology Mid‑importance

	This article is within the scope of WikiProject Pharmacology, a collaborative effort to improve the coverage of Pharmacology on Wikipedia. If you would like to participate, please visit the project page, where you can join the discussion and see a list of open tasks.PharmacologyWikipedia:WikiProject PharmacologyTemplate:WikiProject Pharmacologypharmacology articles
Mid	This article has been rated as Mid-importance on the project's importance scale.

On 28 May 2022, it was proposed that this article be moved to Gallium Ga 68 gozetotide. The result of the discussion was Moved to Gallium (68Ga) gozetotide.

Reveiw comments

DGG writes in review comments "You need to write first about it as a chemical, and after that about the therapeutic use." But there's no cite for that (incompatible with DGG's insistence on reliable sources, true?) Does any such rule really exist, or did DGG just make it up? 73.119.18.232 (talk) 23:28, 25 February 2022 (UTC)[reply]

I don't think there is such a rule. MOS:MED#Drugs, treatments, and devices says to "[i]ndicate the drug class and family and the main indications" in the lead, while the section "Chemistry" comes below all clinical sections. --ἀνυπόδητος (talk) 08:37, 28 May 2022 (UTC)[reply]

Requested move 28 May 2022

The following is a closed discussion of a requested move. Please do not modify it. Subsequent comments should be made in a new section on the talk page. Editors desiring to contest the closing decision should consider a move review after discussing it on the closer's talk page. No further edits should be made to this discussion.

The result of the move request was: Moved to Gallium (68Ga) gozetotide. (closed by non-admin page mover) — Ceso femmuin mbolgaig mbung, mellohi! (投稿) 04:54, 23 June 2022 (UTC)[reply]

Gallium 68 PSMA-11 → Gallium Ga 68 gozetotide – Use the INN instead of the brand name Whywhenwhohow (talk) 06:38, 28 May 2022 (UTC)[reply]

I support moving to the INN per MOS:MED#Drugs, treatments, and devices. However, "Gallium Ga 68 gozetotide" is the USAN; the INN is Gallium (⁶⁸Ga) gozetotide ([1], click on "View Synonyms"). Sorry for nitpicking. --ἀνυπόδητος (talk) 08:35, 28 May 2022 (UTC)[reply]

I don't think we can do superscripts in article titles. (I support INN, or any generic name, or as close as we can actually get to that in practice.) WhatamIdoing (talk) 17:07, 28 May 2022 (UTC)[reply]

@Anypodetos: I agree that we should use the INN when possible instead of the USAN.^[1] @WhatamIdoing: There are some articles where the title doesn't have a superscript but the DISPLAYTITLE does — for example, Flortaucipir (18F) where the INN is flortaucipir (¹⁸F)^[2]. There is an archived discussion of the naming of isotope containing drugs. --Whywhenwhohow (talk) 23:04, 28 May 2022 (UTC)[reply]

That sounds like a solution to me. WhatamIdoing (talk) 00:44, 30 May 2022 (UTC)[reply]

I support Whywhenwhohow idea (There are some articles where the title doesn't have a superscript but the DISPLAYTITLE does — for example, Flortaucipir (18F) where the INN is flortaucipir (18F)[2].)--Ozzie10aaaa (talk) 11:58, 1 June 2022 (UTC)[reply]

Move to Gallium (⁶⁸Ga) gozetotide, as suggested by Anypodetos (talk · contribs): The use of parentheses for the isotopomer matches most other radiopharmaceuticals. –LaundryPizza03 (d c̄) 21:42, 18 June 2022 (UTC)[reply]

The discussion above is closed. Please do not modify it. Subsequent comments should be made on the appropriate discussion page. No further edits should be made to this discussion.

References

^ World Health Organization (2021). "International nonproprietary names for pharmaceutical substances (INN): recommended INN: list 85" (PDF). WHO Drug Information. 35 (1). hdl:10665/340684.
^ World Health Organization (2016). "International nonproprietary names for pharmaceutical substances (INN): recommended INN: list 76". WHO Drug Information. 30 (3). hdl:10665/331020.

[1] World Health Organization (2021). "International nonproprietary names for pharmaceutical substances (INN): recommended INN: list 85" (PDF). WHO Drug Information. 35 (1). hdl:10665/340684.

[2] World Health Organization (2016). "International nonproprietary names for pharmaceutical substances (INN): recommended INN: list 76". WHO Drug Information. 30 (3). hdl:10665/331020.

[1]

[2]

Talk:Gallium (68Ga) gozetotide

Reveiw comments

Requested move 28 May 2022

References

Navigation menu

Search